On this episode of MesoTV, our Patient Services Director, Julie White, sits down with Melissa Culligan, PhD, RN. Melissa is the Director of Thoracic Surgery Research at Temple University Hospital and the Co-Director of the Temple Health Mesothelioma and Pleural Disease Program. She goes through the details of thoracic surgery…
On this episode of MesoTV, join our Patient Services Director, Julie White, as she speaks with Marjorie Zauderer, MD, MS, FACP, and Lee Krug, MD, about the eVOLVE meso clinical trial for patients with pleural mesothelioma. Our SponsorsMesoTV is a program by the Mesothelioma Applied Research Foundation. This program is made…
Mesothelioma is one of the rarest cancers so there are always clinical trials going on to advance research efforts. This session presents on four different clinical trial areas: immune checkpoint blockades, targeted therapies, anti-angiogenesis, and viral and neoantigen therapies. These sessions are presented by:Marjorie Zauderer, MD, Westchester Medical CenterMelina Marmarelis, MD,…
Peritoneal mesothelioma patients have a few different treatment options available. This session discusses two options: surgery as well as hyperthermic intraperitoneal chemotherapy (HIPEC). This session is presented by:Jason Foster, MD, University of NebraskaTravis Grotz, MD, Mayo Clinic This is a recording of a session at the 2024 International Symposium on Malignant…
A mesothelioma diagnosis and recurrence monitoring has many facets. Patients, when seeing their oncologists, may hear information about imaging, biopsies, pathology, and biomarkers and genetic analysis. These sessions will focus on each of these areas. These sessions are presented by:Christopher Straus, MD, University of ChicagoAndrea Wolf, MD, Mount SinaiJennifer Sauter, MD,…
These sessions showcase case studies over dual compartment disease and immunotherapy vs. chemotherapy. These sessions are presented by:R. Taylor Ripley, MD, Baylor College of MedicineManish Patel, DO, University of Minnesota This is a recording of a session at the 2024 International Symposium on Malignant Mesothelioma. This symposium is made possible by…
Surgery is vital option for treatment for many patients with pleural mesothelioma. This session discusses how pleural surgery works and why it is an option for some patients. This session is presented by:Chuong Hoang, MD, National Cancer Institute This is a recording of a session at the 2024 International Symposium on…
Mesothelioma treatments are diverse. When a patient sees their oncologist, they may hear differing treatment options. These sessions focus on the different tools for treatment such as: chemotherapy, immunotherapy, combination therapies, and radiotherapy. These sessions are presented by:Hedy Kindler, MD, University of ChicagoKeith Cengel, MD, PhD, University of Pennsylvania This is…
Cannabis is popular among mesoethelioma patients for pain management as a complementary treatment. This session focuses on how cannabis can help mesothelioma patients in pain management as well as quality of life while also discussing where issues may lie. This session is presented by:Carol Parise, PhD, Sutter Health This is a…
CAR-T (Chimeric antigen receptor) cell therapy is a type of immunotherapy that uses a patient’s T cells to attack cancer cells. T cells are white blood cells that fight infection and illness, but cancer cells can sometimes trick the immune system. CAR T-cell therapy helps the body’s immune system see…









